Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiomics Analysis of Genetics and Epigenetics Reveals Pathogenesis and Therapeutic Targets for Atrial Fibrillation. | Biomed Res Int | 2021 | 33834070 | PubTator, text mining | PubMed |
| Biocompatibility Evolves: Phenomenology to Toxicology to Regeneration. | Adv Healthc Mater | 2021 | 33829678 | PubTator, text mining | PubMed |
| Selected Abstracts from the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference. | J Clin Immunol | 2021 | 33822308 | PubTator, text mining | PubMed |
| Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant. | Front Cardiovasc Med | 2021 | 33816577 | PubTator, text mining | PubMed |
| A Clot Twist: Extreme Variation in Coagulotoxicity Mechanisms in Mexican Neotropical Rattlesnake Venoms. | Front Immunol | 2021 | 33815366 | PubTator, text mining | PubMed |
| Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H. | J Immunol | 2021 | 33811105 | PubTator, text mining | PubMed |
| Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen. | Cancers (Basel) | 2021 | 33810334 | PubTator, text mining | PubMed |
| Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing. | Life (Basel) | 2021 | 33807613 | PubTator, text mining | PubMed |
| Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses. | Viruses | 2021 | 33804519 | PubTator, text mining | PubMed |
| Factor XIII Activity Might Already Be Impaired before Veno-Venous ECMO in ARDS Patients: A Prospective, Observational Single-Center Cohort Study. | J Clin Med | 2021 | 33799338 | PubTator, text mining | PubMed |
| Tremors: A concept analysis. | Nurs Open | 2021 | 33797860 | PubTator, text mining | PubMed |
| Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. | PeerJ | 2021 | 33777535 | PubTator, text mining | PubMed |
| Patient-Specific Modelling of Blood Coagulation. | Bull Math Biol | 2021 | 33772645 | PubTator, text mining | PubMed |
| Congenital Combined Bleeding Disorders, a Comprehensive Study of a Large Number of Iranian Patients. | Clin Appl Thromb Hemost | 2021 | 33764796 | PubTator, text mining | PubMed |
| Discovery of Protein Modifications Using Differential Tandem Mass Spectrometry Proteomics. | J Proteome Res | 2021 | 33749263 | PubTator, text mining | PubMed |
| Chemical Evolution of Antivirals Against Enterovirus D68 through Protein-Templated Knoevenagel Reactions. | Angew Chem Int Ed Engl | 2021 | 33749121 | PubTator, text mining | PubMed |
| Quantitative proteome profiling stratifies fibroepithelial lesions of the breast. | Oncotarget | 2021 | 33747363 | PubTator, text mining | PubMed |
| Prolonged activated partial thromboplastin time secondary to factor XII deficiency in two surgical patients. | Oxf Med Case Reports | 2021 | 33732475 | PubTator, text mining | PubMed |
| Factor XII deficiency in asymptomatic Saudi population: A retrospective cohort study. | Saudi J Biol Sci | 2021 | 33732086 | PubTator, text mining | PubMed |
| Mapping specificity, cleavage entropy, allosteric changes and substrates of blood proteases in a high-throughput screen. | Nat Commun | 2021 | 33727531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=53